Please assess the completion status of the following clinical trial:

Trial Title: Development of Imaging Biomarkers for Voice After Pediatric Airway Reconstruction

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Study Patients~Inclusion Criteria:~1. Ages of 3-30 years,~2. No prior airway surgery~3. Able to undergo the evaluation protocol~Exclusion Criteria:~1.) Patients who have undergone any prior airway reconstruction and/or have a disability that precludes them from completing the evaluation~Control Patients~Inclusion Criteria:~1. Age of 3-30 years~2. No prior history of intubation injury or airway/laryngeal surgery~3. Normal hearing~4. Normal voice assessment performed by a certified speech-language pathologist 5.) Undergoing a non-airway surgical procedure such as adenoidectomy, tonsillectomy, ear tubes, and neck mass removal.~Exclusion Criteria:~1. Has had airway or laryngeal surgery~2. History of a voice or hearing disorder~3. History of neonatal intubation over 14 days~4. Have a disability that precludes them from completing the evaluation

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 30 Years
- Healthy Volunteers: t

Study Arms:
- Study: Airway Reconstruction Patients (Type: EXPERIMENTAL): These participants have significant airway abnormalities that require invasive surgery, such as Laryngotracheoplasty, to rectify, and whose voice quality may suffer as a result of the surgery. The goal of this study is to improve voice outcomes of these patients, and their clinical data will be collected.
- Control: Normal Airway Patients (Type: EXPERIMENTAL): These participants have normal airways and voice who will undergo a microlaryngoscopy and voice evaluation, the data from which will be compared to study patients.

Based on this trial design, predict the completion outcome and termination type (if applicable).